Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Covid-19 Vaccines: What's Coming and When? -- 2nd -2-

11/20/2020 | 01:54pm EST

Bharat Biotech of India, in collaboration with the Indian Council of Medical Research, has developed a vaccine, Covaxin, using an inactivated virus strain. A university in India said a Phase 3 trial of the vaccine began there in mid-November.

Jonathan D. Rockoff, Chao Deng, Raffaele Huang, Yan Wu, Georgi Kantchev, Jared S. Hopkins and Dasl Yoon contributed to this article.

Write to Ana Rivas at ana.rivas@wsj.com, Peter Loftus at peter.loftus@wsj.com and Alberto Cervantes at Alberto.Cervantes@wsj.com

(END) Dow Jones Newswires

11-20-20 1353ET

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.07% 7650 Delayed Quote.4.38%
BIONTECH SE 2.13% 105.43 Delayed Quote.26.63%
JOHNSON & JOHNSON -0.40% 161.73 Delayed Quote.3.18%
MODERNA, INC. 6.27% 132.98 Delayed Quote.19.79%
PFIZER INC. -0.05% 36.48 Delayed Quote.-0.84%
All news about ASTRAZENECA PLC
05:50pASTRAZENECA : Brazil announces incoming vaccine cargo amid supply concerns
AQ
02:43pPfizer-BioNTech agree to supply WHO co-led COVID-19 vaccine scheme -sources
RE
01:54pPfizer cuts vaccine deliveries by as much as half to some EU countries
RE
11:31aIndia to begin commercial vaccine exports with shipments to Brazil, Morocco
RE
11:20aEuropean ADRs Edge Lower in Thursday Trading
MT
10:48aSouth Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII
RE
10:07aCOVID-19 vaccine production unaffected by deadly Indian fire, company says
RE
09:26aIndia's vaccine diplomacy in south Asia pushes back against China
RE
09:18aASTRAZENECA : 5 dead in fire at Indian vaccine maker, Covishield production not ..
AQ
09:10aFILING DATA AFTER APPLYING FOR AN IN : Drafting And Practice Insights
AQ
More news
Financials (USD)
Sales 2020 26 394 M - -
Net income 2020 2 973 M - -
Net Debt 2020 13 212 M - -
P/E ratio 2020 41,9x
Yield 2020 2,68%
Capitalization 138 B 138 B -
EV / Sales 2020 5,72x
EV / Sales 2021 4,96x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 126,13 $
Last Close Price 105,02 $
Spread / Highest target 48,6%
Spread / Average Target 20,1%
Spread / Lowest Target -19,9%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC4.38%136 895
JOHNSON & JOHNSON3.18%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.84%202 881